• Tarek Gammoudi
    Tarek Gammoudi Commented
    · Mon at 11:36 PM ·
  • Inc.
    Inc. wrote a new blog entry:
    Inc.com, the daily resource for entrepreneurs...
    Visit website
    · Mon at 11:23 PM ·
    This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent
    This Breakthrough Cancer Treatment Can Cut Risk by 42 Percent
    A groundbreaking phase 3 clinical trial reveals that a personalized mRNA vaccine from Merck and Moderna significantly cuts the risk of melanoma returning.
    Tarek Gammoudi
    Tarek Gammoudi
    Encouraging news for melanoma patients. Personalized mRNA vaccines are a promising direction, though long-term data will matter. #Health

More from the community

Browse all community posts →